Go Deep
vTv Therapeutics Inc.
vTv Therapeutics Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,696 | -38.2 | 1.38 | 0.00 | 2,612.96 |
| Oct 2026 | 21,686 | -38.3 | 1.39 | 0.00 | 2,619.98 |
| Oct 2026 | 21,833 | -36.9 | 1.33 | 0.00 | 2,513.73 |
| Oct 2026 | 21,777 | -37.4 | 1.35 | 0.00 | 2,554.35 |
| Oct 2026 | 21,650 | -38.7 | 1.40 | 0.00 | 2,640.16 |
| Oct 2026 | 21,661 | -38.6 | 1.40 | 0.00 | 2,626.55 |
| Oct 2026 | 21,746 | -37.7 | 1.37 | 0.00 | 2,563.65 |
| Oct 2026 | 21,972 | -35.5 | 1.28 | 0.00 | 2,421.68 |
vTv Therapeutics Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 36,839,000.0 | 0.0 | 0.0 |
| Net Profit | -13,054,000.0 | 24,134,000.0 | -7,138,000.0 | -8,698,000.0 |
| EPS | -1.1 | 1.9 | -0.6 | -1.1 |
vTv Therapeutics Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 1,017,000.0 | 0.0 | 2,018,000.0 |
| Net Profit | -26,974,000.0 | -18,462,000.0 | -20,250,000.0 | -19,164,000.0 |
| EPS | -3.2 | -3.2 | -9.7 | -10.4 |
vTv Therapeutics Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 89,899,000.0 | 38,266,000.0 | 11,018,000.0 | 33,238,000.0 | — |
| Total Liabilities | 25,462,000.0 | 23,965,000.0 | 29,567,000.0 | 27,399,000.0 | — |
| Total Equity | 64,437,000.0 | 12,199,000.0 | -24,680,000.0 | -10,740,000.0 | — |
Owes vs Owns
vTv Therapeutics Inc. owed $0.10 for every $1 it owned in Jun 2026, down from $0.82 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.10× | 0.28× | 0.63× | 2.68× | 0.82× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
vTv Therapeutics Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 98.9%Other assets 1.1%
How it's funded — Dec 2025
Payables 1.3%Other liabilities 27.1%Shareholders' equity 71.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 88.9 | 36.7 | 9.4 | 12.1 |
| Receivables | 0.0 | 0.1 | 0.1 | 12.4 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.2 | 0.4 | 0.6 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 5.6 |
| Other assets | 1.0 | 1.3 | 1.1 | 2.6 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.2 | 0.2 | 0.2 |
| Long-term debt | 0.0 | 0.0 | 0.2 | 0.3 |
| Payables | 1.1 | 0.9 | 4.1 | 2.5 |
| Other liabilities | 24.3 | 22.9 | 25.1 | 24.4 |
| Shareholders' equity | 64.4 | 14.3 | -18.5 | 5.8 |
| Net tangible assets | 64.4 | 12.2 | -24.7 | -10.7 |
vTv Therapeutics Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -25,255,000.0 | -25,307,000.0 | -19,081,000.0 | -16,022,000.0 | — |
| Investing Activities | 0.0 | 0.0 | 4,404,000.0 | -21,000.0 | — |
| Financing Activities | 77,441,000.0 | 52,607,000.0 | 11,997,000.0 | 14,754,000.0 | — |